StonvexLoading…
StonvexStonvexStonvexCore line items from CMCM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $164.51M | $110.54M | $94.30M | $128.18M |
Operating Income | $-25.66M | $-59.90M | $-29.55M | $-32.71M |
Net Income | $-36.85M | $-84.60M | $-84.92M | $-74.45M |
EPS (Diluted) | $-0.03 | $-0.42 | $-0.41 | $-0.36 |
Total Assets | $669.78M | $754.09M | $793.42M | $745.15M |
Total Liabilities | $389.75M | $451.71M | $418.69M | $294.99M |
Cash & Equivalents | $215.44M | $251.12M | $284.54M | $219.77M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 1.53B | 1.50B | 1.47B | 1.44B |